Wistar's Dr. Andrew Hu (IMAGE)
Caption
Wistar and collaborators from the University of Notre Dame are developing anticancer compounds targeting a pathway of the endoplasmic reticulum (ER) stress response implicated in the development of multiple myeloma (MM), chronic lymphocytic leukemia (CLL) and lymphoma.
Credit
The Wistar Institute
Usage Restrictions
None
License
Licensed content